| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/01/2010 | WO2010072166A1 Preparation method of dihydroindene amide compounds,their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor |
| 07/01/2010 | WO2010072155A1 Pyrimidine derivative, preparation method and use thereof |
| 07/01/2010 | WO2010072147A1 Benzisoxazole piperidinyl derivatives, pharmaceutical compositions comprising the derivatives and their use |
| 07/01/2010 | WO2010072144A1 Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof |
| 07/01/2010 | WO2010072109A1 A sustained release system for tumor treating medicament |
| 07/01/2010 | WO2010072105A1 A enteric formulation of duloxetine and its core and prepration method |
| 07/01/2010 | WO2010072050A1 Use of forsythoside a in manufacture of medicaments for treating hepatitis b |
| 07/01/2010 | WO2010071988A1 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging |
| 07/01/2010 | WO2010071944A1 Quinazolinone compounds |
| 07/01/2010 | WO2010071941A1 Plant extracts from acronychia species and their use |
| 07/01/2010 | WO2010056309A3 Methods and compositions related to targeting monoacylglycerol lipase |
| 07/01/2010 | WO2010054167A3 Limited proteolysis of cd2ap and progression of renal disease |
| 07/01/2010 | WO2010054024A3 1, 2 -thiazol yl derivatives as cannabinoid receptor ligands |
| 07/01/2010 | WO2010051534A3 Method for apcdd1 mediated regulation of hair growth and pigmentation and mutants thereof |
| 07/01/2010 | WO2010046933A3 Pharmaceutical compositions of taste-masked linezolid |
| 07/01/2010 | WO2010046912A3 Thiophene containing analogues of fluconazole as antifungal agents and process for their preparation |
| 07/01/2010 | WO2010046445A3 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| 07/01/2010 | WO2010045395A3 Curcumin analog compositions and related methods |
| 07/01/2010 | WO2010045381A3 Antimicrobial agents that target bacterial vkor |
| 07/01/2010 | WO2010045258A3 Spirocyclic gpr40 modulators |
| 07/01/2010 | WO2010044094A3 A topical composition for the treatment of erectile dysfunction |
| 07/01/2010 | WO2010043408A3 Microencapsulated fesoterodine |
| 07/01/2010 | WO2010042843A3 Composition and method for treating dry eye syndrome |
| 07/01/2010 | WO2010042596A3 Photo-activated protecting groups |
| 07/01/2010 | WO2010041279A3 Sustained release drug delivery system |
| 07/01/2010 | WO2010039654A3 Topical treatment of skin infection |
| 07/01/2010 | WO2010037851A3 Indole derivatives suitable for imaging neuroinflammation |
| 07/01/2010 | WO2010037050A3 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods |
| 07/01/2010 | WO2010036567A3 Harmine compounds for promoting bone growth |
| 07/01/2010 | WO2010036329A3 Process for making quinolone compounds |
| 07/01/2010 | WO2010034003A3 Benzylthiotetrazole inhibitors of store operated calcium release |
| 07/01/2010 | WO2010033981A3 5-azaindole bisphosphonates |
| 07/01/2010 | WO2010033980A3 4-azaindole bisphosphonates |
| 07/01/2010 | WO2010033978A3 IMIDAZO[1,2-α ]PYRIDINYL BISPHOSPHONATES |
| 07/01/2010 | WO2010033977A3 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 07/01/2010 | WO2010033832A3 Estriol formulations |
| 07/01/2010 | WO2010033822A3 Therapeutic and diagnostic strategies |
| 07/01/2010 | WO2010033726A3 Drug delivery composition comprising a self-assembled gelator |
| 07/01/2010 | WO2010033678A3 Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt |
| 07/01/2010 | WO2010030983A3 Pyrazole carboxamide inhibitors of factor xa |
| 07/01/2010 | WO2010030785A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 07/01/2010 | WO2010030395A3 Withaferin a analogs and uses thereof |
| 07/01/2010 | WO2010029571A3 Modified release ramipril compositions and uses thereof |
| 07/01/2010 | WO2010028842A3 Phenyl malonic acid derivatives |
| 07/01/2010 | WO2010028207A9 Method of treatment of attention deficit/hyperactivity disorder (adhd) |
| 07/01/2010 | WO2010028190A3 Compounds, compositions and methods of using same for modulating uric acid levels |
| 07/01/2010 | WO2010028187A3 Methods and compositions for the treatment of cancer |
| 07/01/2010 | WO2010027594A3 Cinnamic acid-based oligomers and uses thereof |
| 07/01/2010 | WO2010025459A3 Novel anti-arrhythmia agent |
| 07/01/2010 | WO2010025138A3 Pyrimidine compounds |
| 07/01/2010 | WO2010024956A3 Antihistamine and antihistamine-like nasal application, products, and method |
| 07/01/2010 | WO2010024930A3 Cortistatin analogues and syntheses therof |
| 07/01/2010 | WO2010024549A3 Bone filler containing a sustained-release therapeutic agent for osteoporosis |
| 07/01/2010 | WO2010016043A8 Treatment of retinal degeneration |
| 07/01/2010 | WO2010008719A9 Oral pharmaceutical formulations of vla-4 antagonists |
| 07/01/2010 | WO2010005876A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/01/2010 | WO2010003974A3 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 07/01/2010 | WO2010000851A3 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/01/2010 | WO2009154777A4 Process for preparing and drying solid rasagiline base |
| 07/01/2010 | WO2009154739A3 Smoothened receptor modulators |
| 07/01/2010 | WO2009150238A3 Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives |
| 07/01/2010 | WO2009114097A3 Method of modulating t cell-dependent immune responses |
| 07/01/2010 | WO2009106502A3 Implant and method for the manufacture thereof |
| 07/01/2010 | WO2009059239A3 REDUCING Aβ42 LEVELS AND Aβ AGGREGATION |
| 07/01/2010 | WO2009049234A3 Methods of treating coagulopathy |
| 07/01/2010 | WO2006110775A3 Antisense oligonucleotides for modifying expression of acc1 and acc2 and for controlling metabolic disorders |
| 07/01/2010 | US20100170000 Rna constructs |
| 07/01/2010 | US20100169995 Targeted gene disruptions in the iqgap2 gene |
| 07/01/2010 | US20100169994 Animal model |
| 07/01/2010 | US20100169989 Use of Follistatin-Like Related Gene (FLRG) to Increase Muscle Mass |
| 07/01/2010 | US20100168807 Bioactive terpolymer compositions and methods of making and using same |
| 07/01/2010 | US20100168685 Serially Dispensable Antiseptic Wet Wipes Moistened with Tincture of Green Soap |
| 07/01/2010 | US20100168250 Use of cyclohexanehexol derivatives in the treatment of ocular disease |
| 07/01/2010 | US20100168249 Composition containing reduced coenzyme q10, and method for stabilizing the composition |
| 07/01/2010 | US20100168248 Process for producing enriched fractions of tetrahydroxycurcumin and tetrahydrotetrahdroxy-curcumin from the extracts of curcuma longa |
| 07/01/2010 | US20100168247 Solid composites of a calcium receptor-active compound |
| 07/01/2010 | US20100168246 Amine compounds and inhibiting neurotransmitter reuptake |
| 07/01/2010 | US20100168245 Preparation of (r,r)-fenoterol and (r,r)-or (r,s)-fenoterol analogues and their use in treating congestive heart failure |
| 07/01/2010 | US20100168244 Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/01/2010 | US20100168243 Renin Inhibitors |
| 07/01/2010 | US20100168242 Polymorphs of suberoylanilide hydroxamic acid |
| 07/01/2010 | US20100168241 Treatment of acne disease states, notably acne vulgaris |
| 07/01/2010 | US20100168240 Substituted dibenzoic acid derivatives and use thereof |
| 07/01/2010 | US20100168239 Use of Rasagiline for the Treatment of Multiple System Atrophy |
| 07/01/2010 | US20100168238 Pharmaceutical composition containing phloroglucinol and paracetamol |
| 07/01/2010 | US20100168233 Terbinafine formulation |
| 07/01/2010 | US20100168232 Oligomer-Anticholinergic Agent Conjugates |
| 07/01/2010 | US20100168231 Target enzyme for the treatment of acne |
| 07/01/2010 | US20100168229 Process for the preparation of optically active compounds using transfer hydrogenation |
| 07/01/2010 | US20100168228 Novel chemotherapeutic agents against inflammation and cancer |
| 07/01/2010 | US20100168227 Preventative Treatment and Remission of Allergic Diseases |
| 07/01/2010 | US20100168225 Small-Molecule Hepatitis C Virus (HCV) NS3/4A Serine Protease Inhibitors |
| 07/01/2010 | US20100168224 Hypoglycemic Activity of Osthole |
| 07/01/2010 | US20100168223 7-Hydroxy Chromones As Potent Antioxidants |
| 07/01/2010 | US20100168222 Novel use of sargachromenol |
| 07/01/2010 | US20100168221 Pharmaceutical composition for treating hepatitis b virus and health food product having hepatitis b virus inhibiting effects |
| 07/01/2010 | US20100168220 Plant extract composition for treating hepatitis c |
| 07/01/2010 | US20100168219 Chronic inflammation and transplantation |
| 07/01/2010 | US20100168218 Method of reducing food intake |
| 07/01/2010 | US20100168217 Sulfamatobenzothiophene derivatives |